[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: Injecting one dose of 1 ml placebo containing normal saline (0.9% NaCl solution) in non-dominant arm on days 0 and 21", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group: Injecting one dose of 1 ml solution of SpikoGen\u00ae vaccine containing recombinant SARS-CoV-2-S protein and Advax\u2122 and CpG adjuvants in the non-dominant arm on days 0 and 21", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2301, "treatment_name": "Advax-sm adjuvant+sars-cov-2 spike (s) protein subunit vaccine", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]